Item type: | Article | ||||
---|---|---|---|---|---|
Journal or Publication Title: | Clinical Neurology and Neurosurgery | ||||
Publisher: | ELSEVIER SCIENCE BV | ||||
Place of Publication: | AMSTERDAM | ||||
Volume: | 172 | ||||
Page Range: | pp. 177-182 | ||||
Date: | 2018 | ||||
Institutions: | Medicine > Lehrstuhl für Neurochirurgie Medicine > Abteilung für Neuropathologie Medicine > Lehrstuhl für Strahlentherapie | ||||
Identification Number: |
| ||||
Keywords: | LOW-GRADE GLIOMAS; GUIDED SURGERY; RESECTION; PERFORMANCE; MICROSCOPE; F-18-FET; Low grade glioma; Fluorescence-guided surgery; Fluorescein sodium; FET-PET; FDG-PET-CT; Pilocytic astrocytoma; Oligodendroglioma; Anaplastic astrocytoma; YELLOW 560 nm filter | ||||
Dewey Decimal Classification: | 600 Technology > 610 Medical sciences Medicine | ||||
Status: | Published | ||||
Refereed: | Yes, this version has been refereed | ||||
Created at the University of Regensburg: | Yes | ||||
Item ID: | 46801 |
Abstract
Objectives: We report on five patients with gadolinium-negative (non-enhancing magnetic resonance imaging-MRI) but F-18-fluoroethyl tyrosine positron-emission tomography (FET-PET) positive glioma (NEG) undergoing surgery under fluorescence-guidance with fluorescein sodium 10% (FL, Alkon, Germany) in combination with a dedicated light filter (YELLOW 560 nm, Carl Zeiss Meditec, Germany). Patients ...
Abstract
Objectives: We report on five patients with gadolinium-negative (non-enhancing magnetic resonance imaging-MRI) but F-18-fluoroethyl tyrosine positron-emission tomography (FET-PET) positive glioma (NEG) undergoing surgery under fluorescence-guidance with fluorescein sodium 10% (FL, Alkon, Germany) in combination with a dedicated light filter (YELLOW 560 nm, Carl Zeiss Meditec, Germany). Patients and method: Since 2017, five patients (3 female, 2 male; mean age 45.4 years) underwent fluorescence guided surgery for supratentorial, intracerebral lesions which showed no contrast-enhancement in the preoperative MRI but were, however, strongly suspicious for gliomas. Accordingly, all patients received a preoperative FET-PET scan and detailed histopathological workup was performed. After giving written informed consent, all patients received 5 mg/kg of FL at the induction of anesthesia. Surgery was conducted under white light and under the YELLOW 560 nm filter. We reviewed the surgical protocols, navigational storage and the image databases of our surgical microscopes for evidence of intraoperative fluorescence that corresponded to the FET-PET positive area. Results: In all patients we found distinct accordances between the FET-PET positive areas and the fluorescing regions within the targeted lesions. Histopathological workup of the fluorescent tissue revealed anaplastic oligodendroglioma, IDH-mutant and 1p/19-codeleted (WHO grade III) (n = 2), anaplastic astrocytoma, IDH-mutant (WHO grade III) (n = 1), oligodendroglioma, IDH-mutant and 1p/19q-codeleted (WHO grade II) (n = 1) and pilocytic astrocytoma (WHO grade I) (n = 1). No adverse events were noted. Discussion and conclusion: Despite the lack of gadolinium-enhancement in the preoperative MRI, all patients intravenously received FL to guide resection. Irrespective of the final grading, FL was extremely helpful in detecting the lesions and in identifying their border zones. In selected patients with NEG, but strong metabolic activity according to the FET-PET, FL may significantly increase the accuracy of surgery.
Metadata last modified: 28 Jul 2021 17:04